Phase II Trial of Depsipeptide (NSC 630176) in Advanced Malignant Melanoma.
Phase of Trial: Phase II
Latest Information Update: 12 May 2016
At a glance
- Drugs Romidepsin (Primary)
- Indications Malignant melanoma
- Focus Adverse reactions; Therapeutic Use
- 01 Mar 2016 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 08 Mar 2012 Planned end date (Aug 2006) added as reported by ClinicalTrials.gov.
- 07 Sep 2005 New trial record.